Key Takeaways Inspire Medical reported Q3 EPS of 38 cents, ahead of the expected loss of 15 cents.INSP's Q3 revenues rise to $224.5 million, driven by market reach and therapy awareness.Inspire Medical raised 2025 EPS guidance to 90 cents to $1.00 while maintaining revenue outlook.Inspire Medical Systems, Inc. (INSP) delivered adjusted earnings per share (EPS) of 38 cents in third-quarter 2025, down 36.7% year over year. The figure compares with the Zacks Consensus Estimate of a loss of 15 cents.INSP’s Reve ...

Inspire Medical Systems Inc (NYSE:INSP) reported better-than-expected third-quarter financial results and raised its FY25 GAAP EPS results above estimates on Monday.Inspire Medical Systems reported quarterly earnings of 38 cents per share which beat the analyst consensus estimate of a loss of 19 cents per share. The company reported quarterly sales of $224.501 million which beat the analyst consensus estimate of $220.467 million.Inspire Medical Systems raised its FY2025 GAAP EPS guidance from $0.40-$0.50 to ...

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

Timothy P. Herbert: Thank you, Ezgi. And thanks everyone for joining our business update call for 2025. I'll start by highlighting some key takeaways of our third quarter results, I'll then discuss our updated 2025 guidance, and Rick will provide a financial review. We will then open the call up for questions. As always, I want to start by reiterating our commitment to put the patient first and deliver strong patient outcomes. We continue to invest in innovation, and clinical evidence as we lead the way in ...

Inspire Medical Systems (NYSE:INSP) Q3 2025 Earnings Call November 03, 2025 05:00 PM ET Speaker5Good afternoon. My name is Dilim, and I'll be your conference operator today. At this time, I'd like to welcome everyone to the Inspire Medical Systems Third Quarter 2025 conference call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there'll be a question-and-answer session. I'll now hand the call over to your first speaker, Ezgi Yagci, the Vice President of Inv ...

Inspire Medical Systems, Inc. November 2025 NYSE: INSP Disclaimer This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts are forward-looking statements. In some cases, you can identify forward-looking statements by terms such as ''may,'' ''will,'' ''should,'' ''expect,'' ''plan,'' ''anticipate,'' ''could,'' "future," "outlook," ''intend,'' ''target,'' ''project,'' ''contemplate ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________________________ FORM 10-Q ________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Delaware 26-1377674 (Address of principal executive offices) (Zip Cod ...

Exhibit 99.1 Inspire Medical Systems, Inc. Announces Third Quarter 2025 Financial Results and Updates 2025 Outlook MINNEAPOLIS, MN - November 3, 2025 - Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire, or the company), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, today reported financial results for the quarter ended September 30, 2025. Recent Business Highlights "The Inspire team had a ...